Siddhartha Laskar Selected Research

Drug Therapy (Chemotherapy)

2/2024	Long-term clinical outcomes of combined modality therapy for advanced-stage Hodgkin lymphoma in the PET era: A retrospective study.
1/2023	Outcome and prognostic variables in childhood rhabdomyosarcoma (RMS) with emphasis on impact of FOXO1 fusions in non-metastatic RMS: experience from a tertiary cancer centre in India.
1/2023	Outcomes of relapsed/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: Experience from a tertiary cancer center.
1/2022	Outcomes and prognostic variables of extracranial germ cell tumors in children and adolescents treated over a decade: A developing world perspective.
1/2022	Radiation Therapy Dose Escalation in Unresectable Ewing Sarcoma: Final Results of a Phase 3 Randomized Controlled Trial.
10/2021	Hodgkin Lymphoma in Adolescent and Young Adults: Real-World Data from a Single Tertiary Cancer Center in India.
1/2021	High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen.
1/2021	Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in India.
11/2020	Outcomes with nondose-dense chemotherapy for Ewing sarcoma: A practical approach for the developing world.
7/2020	Outcomes of T-lymphoblastic lymphoma treated with pediatric ALL-like protocol.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Siddhartha Laskar Research Topics

Disease

24	Neoplasms (Cancer) 02/2024 - 01/2005
7	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 01/2005
5	Hodgkin Disease (Hodgkin's Disease) 02/2024 - 09/2003
4	Lymphoma (Lymphomas) 01/2023 - 06/2006
4	Rhabdomyosarcoma 01/2023 - 10/2017
3	Ewing Sarcoma (Sarcoma, Ewing) 01/2022 - 11/2020
3	Carcinoma (Carcinomatosis) 03/2009 - 10/2005
2	Osteosarcoma (Osteogenic Sarcoma) 11/2021 - 01/2018
2	Giant Cell Tumors (Giant Cell Tumor) 10/2021 - 10/2015
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 08/2007
2	Neoplasm Metastasis (Metastasis) 03/2009 - 01/2005
2	Nasopharyngeal Carcinoma 11/2008 - 01/2004
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2023
1	Cardiotoxicity 10/2022
1	Frailty 10/2022
1	Infections 05/2022
1	COVID-19 05/2022
1	Teratoma (Teratoid Tumor) 01/2022
1	Primitive Neuroectodermal Tumors (PNET) 01/2022
1	Chondrosarcoma 11/2021
1	Chordoma 11/2021
1	Pain (Aches) 11/2021
1	Lung Injury 10/2021
1	Xerostomia 05/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Anemia 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2020
1	Sinus Histiocytosis (Rosai-Dorfman Disease) 03/2020
1	Microsatellite Instability 01/2020
1	Lactic Acidosis 01/2020
1	Thrombosis (Thrombus) 01/2019
1	Lymphadenopathy 01/2019
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Dry Eye Syndromes (Dry Eye Syndrome) 08/2015
1	Pleural Effusion (Pleural Effusions) 01/2011
1	Residual Neoplasm 03/2009
1	Carcinogenesis 02/2008
1	AIDS-Related Complex (ARC) 09/2007
1	Choledochal Cyst (Choledochal Cysts) 01/2007
1	Brain Neoplasms (Brain Tumor) 01/2005

Drug/Important Bio-Agent (IBA)

5	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 03/2009
4	Ifosfamide FDA LinkGeneric 01/2023 - 03/2009
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 01/2021
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2021
3	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 01/2021
2	AnthracyclinesIBA 10/2022 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
1	Lenalidomide (CC 5013)FDA Link 01/2023
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2023
1	VaccinesIBA 05/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2021
1	Vinblastine (Vinblastine Sulfate)FDA Link 10/2021
1	Dacarbazine (DIC)FDA LinkGeneric 10/2021
1	Denosumab FDA Link 10/2021
1	SynaptophysinIBA 12/2020
1	A-factor (Streptomyces)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Interleukin-9 (Interleukin 9)IBA 01/2020
1	CytokinesIBA 01/2020
1	LigandsIBA 01/2020
1	DesminIBA 10/2018
1	MyogeninIBA 10/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Anaplastic Lymphoma KinaseIBA 10/2017
1	Mucin-1 (CA 15-3 Antigen)IBA 04/2016
1	Strontium-90IBA 10/2015
1	Diphosphonates (Bisphosphonates)IBA 10/2015
1	LubricantsIBA 08/2015
1	Cisplatin (Platino)FDA LinkGeneric 03/2009

Therapy/Procedure

28	Radiotherapy 02/2024 - 09/2003
21	Drug Therapy (Chemotherapy) 02/2024 - 01/2004
8	Therapeutics 01/2023 - 09/2007
6	Brachytherapy 01/2018 - 02/2007
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2008 - 09/2007
1	Combined Modality Therapy 02/2024
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Conformal Radiotherapy 03/2020
1	Nephrectomy 01/2019
1	Re-Irradiation 01/2017
1	Conservative Treatment 10/2015
1	Drug Tapering 10/2014
1	Induction Chemotherapy 01/2011
1	Mandibular Osteotomy 03/2009